321906-97-2

Upstream product

• 76513-69-4 (2-trimethylethylsilylethoxy)methyl chloride 
• 321906-87-0 3-benzyl-8-cyclohexyl-1-propyl-7-(2-(trimethylsilyl)ethoxymethyl)xanthine 

Downstream Products

• 321907-01-1 8-cyclohexyl-3-(3-(4-fluorosulfonylbenzamido)propyl)-1-propyl-7-(2-(trimethylsilyl)ethoxymethyl)xanthine 
• 321907-00-0 3-(3-aminopropyl)-8-cyclohexyl-1-propyl-7-(2-(trimethylsilyl)ethoxymethyl)xanthine 
• 595570-76-6 4-{5-[8-cyclohexyl-2,6-dioxo-1-propyl-7-(2-trimethylsilanyl-ethoxymethyl)-1,2,6,7-tetrahydro-purin-3-yl]-pentanoyl}-benzenesulfonyl fluoride 
• 321907-02-2 8-cyclopentyl-3-(3-(4-fluorosulfonylbenzamido)propyl)-1-propyl-7-(2-(trimethylsilyl)ethoxymethyl)xanthine 
• 321906-95-0 8-cyclohexyl-3-(5-(4-fluorosulfonylphenyl)pentyl)-1-propyl-7-(2-(trimethylsilyl)ethoxymethyl)xanthine 
• 321906-93-8 8-cyclohexyl-3-(3-(4-fluorosulfonylphenyl)propyl)-1-propyl-7-(2-(trimethylsilyl)ethoxymethyl)xanthine 
• 321906-90-5 8-cyclohexyl-3-(4-fluorosulfonylbenzyl)-1-propyl-7-(2-(trimethylsilyl)ethoxymethyl)xanthine 
• 321906-99-4 8-cyclohexyl-3-(3-phthalimidopropyl)-1-propyl-7-(2-(trimethylsilyl)ethoxymethyl)xanthine 

Relevant academic research and scientific papers

New irreversible adenosine A1 antagonists based on FSCPX

FSCPX (1) and its amide analogue (2) have been reported to exhibit potent and selective irreversible antagonism of the A1 adenosine receptor (A1AR) when used in in vitro biological preparations. In order to obtain an irreversible As

Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A1-adenosine receptor

FSCPX (1) has been reported to be a potent, selective, and irreversible antagonist for the A1-adenosine receptor (AR). To obtain an irreversible A1AR antagonist with potentially better stability and to further elucidate the effects o